Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial In Progress
666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients